We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Nixes Pronova's Patent Win Against Teva, Par

Law360, New York (September 12, 2013, 5:52 PM EDT) -- Pronova BioPharma Norge AS rendered its patent for the triglyceride-lowering drug Lovaza invalid when it sent a doctor samples of the drug before seeking a patent, the Federal Circuit ruled Thursday...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.